Capital Research Global Investors Boosts UnitedHealth Group Stake

Investment firm increases ownership in healthcare conglomerate by 126.9% in Q3 2025

Published on Mar. 10, 2026

Capital Research Global Investors, a major institutional investor, significantly increased its stake in UnitedHealth Group Incorporated (NYSE: UNH) during the third quarter of 2025. The firm grew its position in the healthcare conglomerate by 126.9%, adding 7,293,009 shares to bring its total ownership to 13,042,049 shares, or approximately 1.44% of UnitedHealth Group's outstanding stock.

Why it matters

UnitedHealth Group is one of the largest healthcare companies in the United States, providing insurance, pharmacy benefits, and other services. Capital Research Global Investors' substantial increase in its UnitedHealth Group holdings signals the investment firm's confidence in the company's long-term growth prospects, which could influence other investors' perceptions of the stock.

The details

According to a regulatory filing, Capital Research Global Investors purchased an additional 7,293,009 shares of UnitedHealth Group during the third quarter, bringing its total position to 13,042,049 shares. This represents a 126.9% increase in the firm's ownership stake in the healthcare conglomerate. Capital Research Global Investors is now the 24th largest shareholder of UnitedHealth Group, owning approximately 1.44% of the company's outstanding stock.

  • Capital Research Global Investors disclosed its increased UnitedHealth Group stake in a filing on March 10, 2026.
  • The firm's additional share purchases occurred during the third quarter of 2025.

The players

Capital Research Global Investors

A major institutional investment firm that manages a diverse portfolio of stocks, bonds, and other assets.

UnitedHealth Group Incorporated

A leading healthcare conglomerate that provides insurance, pharmacy benefits, and other services in the United States.

Got photos? Submit your photos here. ›

The takeaway

Capital Research Global Investors' substantial increase in its UnitedHealth Group holdings suggests the investment firm sees significant long-term value in the healthcare company's stock. This could signal growing confidence among institutional investors in UnitedHealth Group's ability to navigate industry challenges and capitalize on emerging opportunities in the evolving healthcare landscape.